Amn Healthcare Stock Price, News & Analysis

AMN Healthcare Services reported Q4 2021 revenue of $1.36 billion, a 116% increase year-over-year. GAAP EPS rose to $2.42, with adjusted EPS at $2.95. For the full year, revenue reached $3.98 billion, up 66%, and net income hit $327 million, a 363% increase. The company experienced heightened demand for staffing solutions due to labor shortages in healthcare. Operating cash flow was $305 million in 2021, with total debt at $850 million. AMN expanded its stock repurchase authorization by $300 million in February 2022.

AMN Healthcare has announced a donation of $150,000 to support three nonprofit organizations dedicated to nursing. Each recipient, including the National Black Nurses Association, Schwartz Center for Compassionate Healthcare, and DAISY Foundation, will receive $50,000. This initiative aims to enhance diversity, equity, and inclusion in nursing and strengthen community health initiatives. AMN's CEO, Susan Salka, highlighted the importance of these organizations in promoting an equitable healthcare workplace and supporting healthcare professionals' well-being.

AMN Healthcare Services, Inc. (NYSE: AMN) will host a conference call on February 17, 2022, at 5:00 p.m. Eastern Time to discuss its Q4 2021 and full year 2021 financial results, along with the outlook for Q1 2022. The earnings news release will be available after market close on the same day at approximately 4:15 p.m. Eastern Time. The live webcast can be accessed on the company’s website, with a replay available post-call until March 3, 2022.

AMN Healthcare Services (NYSE: AMN) announced preliminary revenue estimates for Q4 2021, projecting revenues between $1.35 billion and $1.36 billion, exceeding previous forecasts. The surge is attributed to strong demand in the Nurse and Allied segment and an additional $70 million in labor disruption revenue. Operating margin and adjusted EBITDA guidance are also raised. CEO Susan R. Salka noted ongoing labor shortages, with expected Q1 2022 revenues over $1.1 billion. Full results will be revealed in February.

AMN Healthcare has appointed Jorge A. Caballero as a new independent director, enhancing its Board of Directors. Caballero, a former Managing Partner at Deloitte's Business Tax Services, has extensive experience in financial management and mergers and acquisitions. His leadership aligns with AMN's commitment to diversity and community engagement. Caballero expressed enthusiasm for joining AMN's board, highlighting his intent to support the company’s stakeholders and commitment to positive change within communities.